日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan

在日本开发和验证用于预测接受托珠单抗治疗的类风湿性关节炎患者严重感染的预测模型

Nanki, Toshihiro; Yamaguchi, Tomohiro; Umetsu, Kosei; Tanabe, Ryunosuke; Maeda, Naoki; Kanazawa, Minori; Furuno, Yuko; Matsuda, Shinichi; Takemoto, Shinya; Asao, Keiko; Kamiuchi, Tatsuya

Effectiveness of Daily Teriparatide in Managing Glucocorticoid-Induced Osteoporosis in Rheumatic Disease Patients After Switching From Bisphosphonate Therapy

每日服用特立帕肽治疗风湿病患者从双膦酸盐治疗转为特立帕肽治疗后,对糖皮质激素诱导的骨质疏松症的疗效

Kaneko, Kaichi; Kaburaki, Makoto; Muraoka, Sei; Shikano, Kotaro; Tanaka, Nahoko; Kawazoe, Mai; Kawai, Shinichi; Nanki, Toshihiro

Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational study

阿巴西普对老年与年轻类风湿性关节炎患者动脉粥样硬化和关节炎的长期影响:一项前瞻性、多中心、观察性研究的3年结果

Yamada, Zento; Muraoka, Sei; Kawazoe, Mai; Hirose, Wataru; Kono, Hajime; Yasuda, Shinsuke; Sugihara, Takahiko; Nanki, Toshihiro

Associations of gut microbiota with disease development, disease activity, and therapeutic effects in patients with systemic lupus erythematosus

肠道菌群与系统性红斑狼疮患者的疾病发展、疾病活动和治疗效果之间的关联

Nishio, Junko; Sato, Hiroshi; Watanabe, Eri; Masuoka, Hiroaki; Aoki, Kotaro; Kawazoe, Mai; Wakiya, Risa; Yamada, Soichi; Muraoka, Sei; Masuoka, Shotaro; Hayashi, Tomoki; Mizutani, Satoshi; Yamada, Zento; Koshiba, Keiko; Irita, Izumi; Kanaji, Miwa; Furukawa, Karin; Yajima, Nobuyuki; Dobashi, Hiroaki; Hirose, Wataru; Ishii, Yoshikazu; Suda, Wataru; Nanki, Toshihiro

Influence of immunosuppressive therapy on longitudinal changes in anti-SARS-CoV-2 spike protein antibodies after two doses of mRNA vaccines in patients with rheumatic diseases

免疫抑制疗法对风湿病患者接种两剂mRNA疫苗后抗SARS-CoV-2刺突蛋白抗体纵向变化的影响

Kawazoe, Mai; Aoki, Kotaro; Hirose, Wataru; Masuoka, Shotaro; Nanki, Toshihiro

Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases

SARS-CoV-2 mRNA疫苗的安全性及免疫抑制药物对风湿病患者不良反应的影响

Kawazoe, Mai; Nishio, Junko; Hirose, Wataru; Furukawa, Karin; Nanki, Toshihiro

Corrigendum: Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease

更正:肺泡上皮细胞衰老影响小鼠纤维化间质性肺疾病的发生和慢性期

Yamada, Zento; Nishio, Junko; Motomura, Kaori; Mizutani, Satoshi; Yamada, Soichi; Mikami, Tetuo; Nanki, Toshihiro

Dose-escalation part of Phase I study of single-agent mosunetuzumab in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma

莫苏妥珠单抗单药治疗复发/难治性B细胞非霍奇金淋巴瘤日本患者的I期研究的剂量递增部分

Munakata, Wataru; Izutsu, Koji; Mishima, Yuko; Nagai, Hirokazu; Ishihara, Yuko; Suzumiya, Junji; Kanakura, Yuzuru; Nanki, Toshihiro; Miyake, Takeshi; Kawasaki, Atsuko; Yoshinaga, Tatsuya; Ishizawa, Kenichi

Senescence of alveolar epithelial cells impacts initiation and chronic phases of murine fibrosing interstitial lung disease

肺泡上皮细胞衰老影响小鼠纤维化间质性肺疾病的发生和慢性期。

Yamada, Zento; Nishio, Junko; Motomura, Kaori; Mizutani, Satoshi; Yamada, Soichi; Mikami, Tetuo; Nanki, Toshihiro

Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry

日本合并风湿性疾病的COVID-19患者的临床特征:一项基于COVID-19全球风湿病联盟医生报告注册库的多中心观察性研究数据。

Kihara, Mari; Sugihara, Takahiko; Asano, Junichi; Sato, Midori; Kaneko, Hiroshi; Muraoka, Sei; Ohshima, Shiro; Nanki, Toshihiro